期刊文献+

基质金属蛋白酶-9在子宫内膜癌组织中的表达水平及临床意义 被引量:5

Expression and clinical significance of matrix metalloproteinases-9 in tissues of endometrial carcinoma
下载PDF
导出
摘要 目的探讨基质金属蛋白酶-9(MMP-9)在子宫内膜癌组织中的表达水平及临床意义。方法收集2009年2月—2012年3月在本院住院的30例子宫内膜癌组织石蜡标本设为实验组1,40例不典型增生内膜组织石蜡标本设为实验组2,40例正常子宫内膜组织石蜡标本设为对照组。应用免疫组织化学染色方法对各组标本进行MMP-9抗原染色,统计阳性染色细胞数量及染色程度。比较各组MMP-9表达情况;分析子宫内膜癌组织MMP-9表达与临床病理参数的关系;采用Cox比例风险模型分析子宫内膜癌预后生存因素。结果实验组1的低表达率明显低于实验组2和对照组,高表达率则明显高于实验组2和对照组(P<0.05);MMP-9蛋白表达情况与病理分级、淋巴结转移情况相关(P<0.05);病理分级、淋巴结转移状态是子宫内膜癌的预后影响因素(P<0.05)。结论 MMP-9在子宫内膜癌组织中特异性高表达,可作为诊断子宫内膜癌诊断及病理分级的参考指标之一,但其表达水平并非子宫内膜癌的独立预后影响因素。 Objective To investigate the expression and clinical significance of matrix metalloproteinases-9( MMP-9) in tissues of endometrial carcinoma. Methods The paraffin samples of tissues in 30 patients with endometrial carcinoma admitted in our hospital from February 2009 to March2012 were selected as experimental group 1 while those in other 40 patients with atypical endometrial hyperplasia and 40 healthy people as experimental group 2 and control group,respectively. Immunohistochemical staining method was used for the MMP-9 staining so as to analyze the counts of cells with positive staining and the staining severity. MMP-9 expression levels were compared,the relationship between MMP-9 expression and clinical pathological parameters in endometrial carcinoma tissues were analyzed and Cox ratio risk model was applied to analyze the prognostic factors of endometrial carcinoma. Results Experimental group 1 was evidently lower in low-expression of MMP-9 than experimental group 2 and apparently higher in high-expression of MMP-9 than the other groups( P〈 0. 05). It was showed that pathological staging and lumph node metastasis were closely associated with MMP-9 protein expression( P〈 0. 05),which were also the risk factors impacting the prognosis of endometrial carcinoma( P〈 0. 05). Conclusion The specific high-expression of MMP-9 in endometrial carcinoma can be considered as one of the referent indexes for diagnosing endometrial carcinoma and its pathological staging,which,however,is not the independent risk factor influencing the prognosis of endometrial carcinoma.
出处 《实用临床医药杂志》 CAS 2014年第15期63-65,69,共4页 Journal of Clinical Medicine in Practice
基金 中国高校医学期刊临床专项资金(NO:11321307)
关键词 子宫内膜癌 基质金属蛋白酶-9 免疫组织化学染色 病理特征 Endometrial carcinoma Matrix metalloproteinases-9 Immunohistochemistry Pathological characteristics
  • 相关文献

参考文献6

  • 1高萍,李晓云,陈晓丽,王雪楠,杨爱军,任英霞.子宫内膜癌中MMP-9、CD44v6的表达及意义[J].中国药物经济学.2013(06)
  • 2Marcin Jedryka,Agnieszka Chrobak,Anna Chelmonska-Soyta,Daria Gawron,Alicja Halbersztadt,Andrzej Wojnar,Jan Kornafel.Matrix metalloproteinase (MMP)-2 and MMP-9 Expression in Tumor Infiltrating CD3 Lymphocytes From Women With Endometrial Cancer[J].International Journal of Gynecological Cancer.2012(8)
  • 3Fang Yu,Qingping Jiang,Ying Zhou,Zhen Yang,Xiaoli Yu,Hao Wang,Zhen Liu,Lijing Wang,Weiyi Fang,Suiqun Guo.Abnormal expression of matrix metalloproteinase-9 (MMP9)correlates with clinical course in Chinese patients with endometrialcancer[J].Disease Markers.2012(5)
  • 4李云云,贺文凤,黄婷婷,申阳,刘秀霞,曹青.PTEN对子宫内膜癌细胞株迁移和侵袭能力的影响[J].中国癌症杂志,2013,23(10):813-820. 被引量:4
  • 5Kai Kessenbrock,Vicki Plaks,Zena Werb.Matrix Metalloproteinases: Regulators of the Tumor Microenvironment[J].Cell.2010(1)
  • 6魏丽惠.重视子宫内膜癌的筛查[J].中华妇产科杂志,2013,48(12):881-883. 被引量:54

二级参考文献31

  • 1IEMAL A, SIEGEL R, WARD E, et al. Cancer statistics, 2009 [ J ] . CA Cancer J Clin, 2009, 59(4): 225-249.
  • 2MATIAS-GUIU X, PRAT J. Molecular pathology of endometrial carcinoma [ J ] . Histopathology, 2013, 62(1): 111-123.
  • 3CULLY M, YOU H, LEVINE A J, et al. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis [ J ] . Nat Rev Cancer, 2006,6(3): 184-192.
  • 4KURAMOTO H. Studies of the growth and cytogenetic properties of human endometrial adenocarcinoma in culture and its development into an estabished line [ J ] . Acta Obstet Gynaecol Jph, 1972, 19(1): 47-58.
  • 5BOCHKOV Y, PALMENBERG A. Translational eciency of EMCV IRES in bicistronic vectors is dependent upon IRES sequence and gene location [ J ] Biotechniques, 2006, 41(3): 283-292.
  • 6HEDDLE C, MAZALEYRAT S L. Development of a screening platform for directed evolution using the reef coral fluorescent protein ZsGreen as a solubility reporter [ J ] . Protein Eng Des Sel, 2007, 20(7): 327-337.
  • 7TIAN T, NAN K J, GUO H, et al. PTEN inhibits the migration and invasion of HepG2 ceils by coordinately decreasing MMP expression via the PI3K/Akt pathway [ J ] . Oneol Rep, 2010, 23(6): 1593-1600.
  • 8KOUL D, PARTHASARATHY R, SHEN R, et al. Suppression of matrix metallopreteinase-2 gene expression and invasion in human glioma ceils by MMAC/PTEN [ J ]. Oncogene, 2001, 20(46): 6669-6678.
  • 9GARCIA-DIOS D A, LAMBRECHTS D, COENEGRACHTS L, et al. High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma [ J ] . Gynecol Oncol, 2013, 128(2): 327-334.
  • 10LI L, ROSS A H. Why is PTEN an important tumor suppressor? [ J ] . J Cell Biochem, 2007, 102(6): 1368-1374.

共引文献56

同被引文献38

  • 1冯力元,吴佳捷.小干扰RNA抑制HMGB1表达对子宫内膜癌细胞侵袭与迁移的影响[J].中南大学学报(医学版),2014,39(1):36-42. 被引量:14
  • 2谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 3Ferlay J, Soerjomataram I, Ervik M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5): E359-386.
  • 4Tang D, Kang R, Zeh HR, et al. High-mobility group box 1 and cancer[J]. Biochim Biophys Acta, 2010, 1799 ( 1/2): 131-140.
  • 5Shang GH, Jia CQ, Tian H, et al. Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer[J]. Respir Med, 2009, 103(12): 1949-1953.
  • 6Ishiguro H, Nakaigawa N, Miyoshi Y, et al. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development[J]. Prostate, 2005, 64(1): 92-100.
  • 7Liu W, Zhang Z, Zhang Y, et al. HMGBl-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway[J]. Cancer Biol Ther, 2015, 16(4): 511-517.
  • 8Wang L, Wang Q, Li HL, et al. Expression of MIR200a, miR93,metastasis-related gene RECK and MMP2/MMP9 in human cervical carcinoma-relationship with prognosis[J]. Asian J Cancer Prev, 2013, 14(3): 2113- 2118.
  • 9Schlueter C, Weber H, Meyer B, et al. Angiogenetic signaling through hypoxia: HMGB 1: an angiogenetic switch molecule[J]. Am J Pathol, 2005, 166(4): 1259-1263.
  • 10Zhu L, Li X, Chen Y, et al. High-mobility group box 1: a novel inducer of the epithelial-mesenchymal transition in colorectal carcinorna[J]. Cancer Lett, 2015, 357(2): 527-534.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部